Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) EBT Margin (2010 - 2026)

Orthofix Medical (OFIX) reported EBT Margin of 11.19% for Q1 2026, up 1751.0% year-on-year from 0.6% in Q1 2025, and down 127.03% quarter-over-quarter from 41.42% in Q4 2025.

Orthofix Medical (OFIX) has 17 years of EBT Margin data on file, last reported at 11.19% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin rose 1751.0% year-over-year to 11.19%; the trailing twelve-month figure through Mar 2026 stood at 4.27% (up 2328.0% YoY), and the FY2025 full-year result was 0.3%, up 1687.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 11.19%, down from 41.42% in the prior quarter.
  • Across five years, EBT Margin topped out at 90.23% in Q4 2023 and bottomed at 37.18% in Q1 2023.
  • A 5-year average of 5.29% and a median of 11.49% in 2025 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin soared 10067 bps in 2023 and sank 10835 bps in 2024, its largest moves.
  • Tracing OFIX's EBT Margin over 5 years: stood at 10.44% in 2022, then soared by 965 bps to 90.23% in 2023, then plunged by 120 bps to 18.12% in 2024, then surged by 329 bps to 41.42% in 2025, then tumbled by 127 bps to 11.19% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods registered 11.19%, 41.42%, and 11.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.98%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 14.12%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 15.57%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.84%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.17%
10 Orthofix Medical 375.38 Mn 254.51 Mn 139.55 Mn -11.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -11.19%
Dec 31, 2025 41.42%
Sep 30, 2025 -11.49%
Jun 30, 2025 -7.43%
Mar 31, 2025 -28.70%
Dec 31, 2024 -18.12%
Sep 30, 2024 -13.55%
Jun 30, 2024 -16.29%
Mar 31, 2024 -20.00%
Dec 31, 2023 90.23%
Sep 30, 2023 -15.43%
Jun 30, 2023 -21.78%
Mar 31, 2023 -37.18%
Dec 31, 2022 -10.44%
Sep 30, 2022 -8.22%
Jun 30, 2022 2.94%
Mar 31, 2022 -4.74%
Dec 31, 2021 -1.90%
Sep 30, 2021 -2.25%
Jun 30, 2021 3.85%
Mar 31, 2021 -5.70%
Dec 31, 2020 9.77%
Sep 30, 2020 5.46%
Jun 30, 2020 -26.96%
Mar 31, 2020 5.37%
Dec 31, 2019 3.48%
Sep 30, 2019 -27.44%
Jun 30, 2019 0.67%
Mar 31, 2019 -4.68%
Dec 31, 2018 9.57%
Sep 30, 2018 -1.19%
Jun 30, 2018 1.81%
Mar 31, 2018 9.75%
Dec 31, 2017 14.22%
Sep 30, 2017 9.02%
Jun 30, 2017 7.95%
Mar 31, 2017 1.57%
Dec 31, 2016 3.42%
Sep 30, 2016 9.25%
Jun 30, 2016 -2.56%
Mar 31, 2016 8.99%
Dec 31, 2015 6.83%
Sep 30, 2015 2.25%
Jun 30, 2015 5.80%
Mar 31, 2015 -7.55%
Dec 31, 2014 1.85%
Sep 30, 2014 4.74%
Jun 30, 2014 6.51%
Mar 31, 2014 -0.77%
Dec 31, 2013 -9.47%
Sep 30, 2013 -17.56%
Jun 30, 2013 5.39%
Mar 31, 2013 10.06%
Dec 31, 2012 19.88%
Sep 30, 2012 16.37%
Jun 30, 2012 12.27%
Mar 31, 2012 14.06%
Dec 31, 2011 -10.84%
Sep 30, 2011 18.77%
Jun 30, 2011 15.58%
Mar 31, 2011 -28.52%
Dec 31, 2010 -1.49%
Sep 30, 2010 10.29%
Jun 30, 2010 11.74%